Siga Technologies (SIGA) Change in Accured Expenses (2010 - 2025)
Siga Technologies' (SIGA) quarterly Change in Accured Expenses came in at $6.3 million in Q3 2025, up 728.17% YoY from $766720.0 in Q3 2024, and up 165.89% on a QoQ basis from -$9.6 million in Q2 2025.
Siga Technologies (SIGA) Change in Accured Expenses (2010 - 2025) Analysis & Trends
Siga Technologies (SIGA) has 16 years of Change in Accured Expenses data on file, last reported at $6.3 million in Q3 2025.
- Quarterly Change in Accured Expenses rose 728.17% year-over-year to $6.3 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $5.0 million (up 346.95% YoY) and the FY2024 annual result came in at -$5.7 million, down 387.43% from the prior year.
- Change in Accured Expenses rose to $6.3 million in Q3 2025, from -$9.6 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $11.0 million in Q3 2021 to a low of -$9.6 million in Q2 2025.
- A 5-year average of $336053.5 and a median of $619665.0 in 2022 frame the typical range for Change in Accured Expenses.
- The widest YoY moves for Change in Accured Expenses: up 728.17% in 2025, down 906.11% in 2025.
- Tracing SIGA's Change in Accured Expenses over 5 years: stood at -$7.6 million in 2021, then jumped by 108.13% to $619665.0 in 2022, then jumped by 161.02% to $1.6 million in 2023, then tumbled by 228.58% to -$2.1 million in 2024, then soared by 405.32% to $6.3 million in 2025.
- The last three Change in Accured Expenses figures came in at $6.3 million (Q3 2025), -$9.6 million (Q2 2025), and $10.4 million (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | 82.00 Mn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | 142.00 Mn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | -219.00 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | -4.00 Mn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | -8.50 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Siga Technologies | 212.67 Mn | 57.70 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 6.35 Mn |
| Sep 30, 2025 | 6.35 Mn |
| Jun 30, 2025 | -9.64 Mn |
| Jun 30, 2025 | -9.64 Mn |
| Mar 31, 2025 | 10.41 Mn |
| Mar 31, 2025 | 10.41 Mn |
| Dec 31, 2024 | -2.08 Mn |
| Dec 31, 2024 | -2.08 Mn |
| Sep 30, 2024 | 766,720.00 |
| Sep 30, 2024 | 766,720.00 |
| Jun 30, 2024 | -957,798.00 |
| Jun 30, 2024 | -957,798.00 |
| Mar 31, 2024 | -3.47 Mn |
| Mar 31, 2024 | -3.47 Mn |
| Dec 31, 2023 | 1.62 Mn |
| Dec 31, 2023 | 1.62 Mn |
| Sep 30, 2023 | 1.52 Mn |
| Sep 30, 2023 | 1.52 Mn |
| Jun 30, 2023 | 1.93 Mn |
| Jun 30, 2023 | 1.93 Mn |